{"nodes": [{"id": "psychopathic traits"}, {"id": "urologist recommendations"}, {"id": "7-8 la"}, {"id": "anti-depressant effects"}, {"id": "traditional approaches"}, {"id": "utilitarian choices"}, {"id": "6-month follow-up"}, {"id": "indigenous cultures"}, {"id": "follow-up assessments"}, {"id": "chronic pain"}, {"id": "emotional empathy scores"}, {"id": "functional connectivity"}, {"id": "single-dose psilocybin"}, {"id": "phenomenological features"}, {"id": "male mice"}, {"id": "suicide attempt"}, {"id": "retrospective measures"}, {"id": "conscious experience"}, {"id": "depression-like behavior"}, {"id": "follow-up surveys"}, {"id": "moral decision-making"}, {"id": "whole-body vibration strength-training"}, {"id": "experimental therapeutics"}, {"id": "\u2019 interest"}, {"id": "cognitive style"}, {"id": "female survivors"}, {"id": "biomedical interventions"}, {"id": "oxytocin administration"}, {"id": "healthy women"}, {"id": "high scores"}, {"id": "decision-making processes"}, {"id": "single capacity"}, {"id": "mental states"}, {"id": "british journal"}, {"id": "active treatment"}, {"id": "healthy individuals"}, {"id": "neurotrophic factor"}, {"id": "cognitive empathy"}, {"id": "medical factors"}, {"id": "adolescent depression"}, {"id": "moral judgments"}, {"id": "emotional experience"}, {"id": "medical outcomes"}, {"id": "unique impact"}, {"id": "emotional empathy"}, {"id": "cognitive capacities"}, {"id": "moral decision"}, {"id": "social cognition"}, {"id": "potential drivers"}, {"id": "magnetic resonance imaging"}, {"id": "late 1960s"}, {"id": "moral decision making"}, {"id": "long-term memory"}, {"id": "psychosocial factors"}, {"id": "psilocybin-assisted psychotherapy"}, {"id": "synaptic density"}, {"id": "moral behaviors"}, {"id": "mean pain severity"}, {"id": "psilocybin"}, {"id": "altruistic decisions"}, {"id": "classic psychedelics"}, {"id": "executive functions"}, {"id": "mid-twentieth century"}, {"id": "white matter tracts"}, {"id": "depressive episode"}, {"id": "depressive disorder"}, {"id": "human behaviors"}, {"id": "social functioning"}, {"id": "add-on therapy"}, {"id": "religious contexts"}, {"id": "cancer-related anxiety"}, {"id": "direct perception"}, {"id": "healthy controls"}, {"id": "emotional empathy task"}, {"id": "psychedelic state"}, {"id": "5-hydroxytryptamine2a agonist"}, {"id": "important role"}, {"id": "dietetic disease"}, {"id": "metabolic risk factors"}, {"id": "important driver"}, {"id": "depressed mood"}, {"id": "recent research"}, {"id": "biomedical enhancement refers"}, {"id": "380-1 la"}, {"id": "functional outcomes"}, {"id": "topical analgesics"}, {"id": "585-7 la"}, {"id": "moderate-dose psilocybin"}, {"id": "depressive behavior"}, {"id": "mental health problems"}, {"id": "religious music"}, {"id": "187-97 la"}, {"id": "moral behavior"}], "links": [{"source": "depressed mood", "target": "adolescent depression", "value": 10}, {"source": "moral behavior", "target": "moral behaviors", "value": 10}, {"source": "cancer-related anxiety", "target": "single-dose psilocybin", "value": 10}, {"source": "psilocybin", "target": "emotional empathy", "value": 10}, {"source": "recent research", "target": "dietetic disease", "value": 10}, {"source": "emotional empathy", "target": "emotional empathy scores", "value": 10}, {"source": "cancer-related anxiety", "target": "anti-depressant effects", "value": 10}, {"source": "classic psychedelics", "target": "phenomenological features", "value": 10}, {"source": "social cognition", "target": "healthy controls", "value": 10}, {"source": "emotional empathy", "target": "emotional empathy task", "value": 10}, {"source": "6-month follow-up", "target": "follow-up surveys", "value": 10}, {"source": "cancer-related anxiety", "target": "active treatment", "value": 10}, {"source": "moral decision-making", "target": "emotional experience", "value": 10}, {"source": "cancer-related anxiety", "target": "\u2019 interest", "value": 10}, {"source": "moral behavior", "target": "psychopathic traits", "value": 10}, {"source": "depressed mood", "target": "psychosocial factors", "value": 10}, {"source": "social cognition", "target": "direct perception", "value": 10}, {"source": "recent research", "target": "recent research", "value": 10}, {"source": "moral decision-making", "target": "altruistic decisions", "value": 10}, {"source": "depressed mood", "target": "potential drivers", "value": 10}, {"source": "cancer-related anxiety", "target": "moderate-dose psilocybin", "value": 10}, {"source": "anti-depressant effects", "target": "whole-body vibration strength-training", "value": 10}, {"source": "6-month follow-up", "target": "depressive disorder", "value": 10}, {"source": "moral behavior", "target": "human behaviors", "value": 10}, {"source": "emotional empathy", "target": "magnetic resonance imaging", "value": 10}, {"source": "cancer-related anxiety", "target": "medical outcomes", "value": 10}, {"source": "social cognition", "target": "oxytocin administration", "value": 10}, {"source": "moral decision-making", "target": "utilitarian choices", "value": 10}, {"source": "depressed mood", "target": "cognitive style", "value": 10}, {"source": "6-month follow-up", "target": "suicide attempt", "value": 10}, {"source": "recent research", "target": "british journal", "value": 10}, {"source": "classic psychedelics", "target": "experimental therapeutics", "value": 10}, {"source": "moral decision-making", "target": "moral decision making", "value": 10}, {"source": "classic psychedelics", "target": "psilocybin-assisted psychotherapy", "value": 10}, {"source": "6-month follow-up", "target": "high scores", "value": 10}, {"source": "cancer-related anxiety", "target": "urologist recommendations", "value": 10}, {"source": "recent research", "target": "585-7 la", "value": 10}, {"source": "depressed mood", "target": "long-term memory", "value": 10}, {"source": "social cognition", "target": "functional outcomes", "value": 10}, {"source": "depressed mood", "target": "unique impact", "value": 10}, {"source": "classic psychedelics", "target": "mid-twentieth century", "value": 10}, {"source": "cancer-related anxiety", "target": "medical factors", "value": 10}, {"source": "anti-depressant effects", "target": "depressive episode", "value": 10}, {"source": "psilocybin", "target": "anti-depressant effects", "value": 10}, {"source": "6-month follow-up", "target": "topical analgesics", "value": 10}, {"source": "classic psychedelics", "target": "psychedelic state", "value": 10}, {"source": "social cognition", "target": "social functioning", "value": 10}, {"source": "moral decision-making", "target": "moral decision", "value": 10}, {"source": "psilocybin", "target": "moral behavior", "value": 10}, {"source": "moral behavior", "target": "biomedical enhancement refers", "value": 10}, {"source": "recent research", "target": "187-97 la", "value": 10}, {"source": "anti-depressant effects", "target": "male mice", "value": 10}, {"source": "classic psychedelics", "target": "conscious experience", "value": 10}, {"source": "emotional empathy", "target": "functional connectivity", "value": 10}, {"source": "6-month follow-up", "target": "metabolic risk factors", "value": 10}, {"source": "emotional empathy", "target": "white matter tracts", "value": 10}, {"source": "cancer-related anxiety", "target": "recent research", "value": 10}, {"source": "anti-depressant effects", "target": "cancer-related anxiety", "value": 10}, {"source": "depressed mood", "target": "retrospective measures", "value": 10}, {"source": "anti-depressant effects", "target": "synaptic density", "value": 10}, {"source": "moral behavior", "target": "biomedical interventions", "value": 10}, {"source": "psilocybin", "target": "social cognition", "value": 10}, {"source": "psilocybin", "target": "recent research", "value": 10}, {"source": "psilocybin", "target": "classic psychedelics", "value": 10}, {"source": "social cognition", "target": "important driver", "value": 10}, {"source": "social cognition", "target": "traditional approaches", "value": 10}, {"source": "recent research", "target": "7-8 la", "value": 10}, {"source": "classic psychedelics", "target": "late 1960s", "value": 10}, {"source": "anti-depressant effects", "target": "neurotrophic factor", "value": 10}, {"source": "depressed mood", "target": "mental health problems", "value": 10}, {"source": "moral behavior", "target": "single capacity", "value": 10}, {"source": "6-month follow-up", "target": "mean pain severity", "value": 10}, {"source": "moral decision-making", "target": "cognitive empathy", "value": 10}, {"source": "psilocybin", "target": "6-month follow-up", "value": 10}, {"source": "moral decision-making", "target": "moral judgments", "value": 10}, {"source": "social cognition", "target": "executive functions", "value": 10}, {"source": "moral decision-making", "target": "decision-making processes", "value": 10}, {"source": "moral decision-making", "target": "emotional empathy", "value": 10}, {"source": "anti-depressant effects", "target": "depression-like behavior", "value": 10}, {"source": "psilocybin", "target": "moral decision-making", "value": 10}, {"source": "emotional empathy", "target": "healthy women", "value": 10}, {"source": "moral behavior", "target": "religious music", "value": 10}, {"source": "recent research", "target": "380-1 la", "value": 10}, {"source": "anti-depressant effects", "target": "depressive behavior", "value": 10}, {"source": "6-month follow-up", "target": "follow-up assessments", "value": 10}, {"source": "emotional empathy", "target": "cognitive empathy", "value": 10}, {"source": "moral behavior", "target": "religious contexts", "value": 10}, {"source": "psilocybin", "target": "cancer-related anxiety", "value": 10}, {"source": "social cognition", "target": "mental states", "value": 10}, {"source": "emotional empathy", "target": "important role", "value": 10}, {"source": "emotional empathy", "target": "healthy individuals", "value": 10}, {"source": "6-month follow-up", "target": "chronic pain", "value": 10}, {"source": "depressed mood", "target": "female survivors", "value": 10}, {"source": "classic psychedelics", "target": "5-hydroxytryptamine2a agonist", "value": 10}, {"source": "anti-depressant effects", "target": "add-on therapy", "value": 10}, {"source": "moral behavior", "target": "cognitive capacities", "value": 10}, {"source": "classic psychedelics", "target": "indigenous cultures", "value": 10}, {"source": "psilocybin", "target": "depressed mood", "value": 10}]}